8-K FOR PRELIM 2019 RESULTS AND PRESS RELEASE

Company

Intellia Therapeutics, Inc.

Filed

January 9, 2020

Period of Report

January 9, 2020

Accession Number

0001564590-20-000550

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →